CAP, Adenylate Cyclase-Associated Protein 1 (CAP1) Peptide
CAP1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all CAP1 products
- CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KAQSGPVRSG PKPFSAPKPQ TSPSPKRATK KEPAVLELEG KKWRVENQEN
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CAP1 antibody,
Alternative Names: CAP1 control peptide, CAP1 antibody Blocking Peptide, Anti-CAP1 Blocking Peptide, Cap Adenylate Cyclase-Associated Protein 1 Blocking Peptide, CAP Blocking Peptide, CAP1-PEN Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CAP1 (CAP, Adenylate Cyclase-Associated Protein 1 (CAP1))
- Background
- The protein encoded by this gene is related to the S. cerevisiae CAP protein, which is involved in the cyclic AMP pathway. The human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin.
- Molecular Weight
- 52 kDa
-
You are here:
